Project Grant HT9425261E148
Award Date 5/15/26
Completion Date 5/14/29
Dollars Obligated $604K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94305, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $1.82M project grant effective May 1, 2026, through April 30, 2030, under the Military Medical Research and Development program (CFDA 12.420). The award supports development of a predictive spatial assay designed to eliminate unnecessary therapeutic interventions in primary ductal carcinoma in situ (DCIS), a form of breast cancer. This research initiative represents a translational...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $7.0 million Project Grant on April 15, 2026, under the Military Medical Research and Development program (CFDA 12.420) to support the TAILORX Clinical Research Extension Award: Advancing Breast Cancer Treatment Stratification Through Spatial Omics and Digital Pathology. The four-year award, with a completion date of April 14, 2030, will be performed at Stanford's Palo Alto, CA location...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $1.528 million project grant on May 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to develop a predictive spatial assay for eliminating unnecessary therapies in primary ductal carcinoma in situ (DCIS). The four-year award, with an ultimate completion date of April 30, 2030, supports advanced biomedical research aimed at improving cancer...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Stanford University a $832,270 Project Grant effective July 1, 2025, through June 30, 2028, under the Military Medical Research and Development program (CFDA 12.420). The award supports high-throughput in vivo lung cancer pharmacogenomics research conducted at Stanford's Palo Alto, California facility. This research initiative will deliver advanced biomedical research services focused on investigating innovative medical...
- The Defense Health Agency awarded The Leland Stanford Junior University a $1.89M project grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on therapeutic inactivation of the MYC oncogene as a treatment for triple-negative breast cancer. The award, issued on May 15, 2026, with an ultimate completion date of April 14, 2029, supports hypothesis-driven biomedical research designed to advance innovative medical solutions addressing critical health...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a Project Grant totaling $1,054,071 under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. This award supports the development of novel inhibitors of NEMO-like kinase for the treatment of Diamond Blackfan Anemia, a rare hematologic disorder. Research will be conducted at Stanford's Palo Alto, California facility over...
- This $469,381.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Leland Stanford Junior University (Stanford University) to engineer cytotoxic lymphocytes to infiltrate ovarian cancer tumors via metabolite-sensing receptors. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing medical solutions for critical health...
- This $370,866 Formula Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research conducted by The Leland Stanford Junior University, a prominent private research university. The grant will fund a 1-year project to uncover synthetically lethal genes that could be targeted in lung cancer in the presence of protein folding stress, with the goal of transforming healthcare for military service members...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a Project Grant totaling $3,128,801 under the Military Medical Research and Development program (CFDA 12.420) to develop a blood test for measuring sleep deprivation and circadian time. The award, effective June 1, 2025, through May 31, 2028, supports advanced biomedical research directed at transforming healthcare for military service members and the broader public. This research initiative...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...